BioCentury | Dec 14, 2017
Clinical News

Erytech's Graspa misses in Phase IIb AML study

...company plans to start a Phase III trial of Graspa to treat pancreatic cancer. The Orphan Europe s.a.r.l....
BioCentury | Dec 8, 2017
Clinical News

Erytech sinks after Graspa miss in AML study

...company plans to start a Phase III trial of Graspa to treat pancreatic cancer. The Orphan Europe s.a.r.l....
BioCentury | Nov 17, 2017
Financial News

Erytech raises $125M, lists on NASDAQ

...for the product in November 2016. Eryaspase comprises L-asparaginase encapsulated in red blood cells. The Orphan Europe s.a.r.l....
BioCentury | Nov 15, 2017
Financial News

Erytech raises $125M, lists on NASDAQ

...for the product in November 2016. Eryaspase comprises L-asparaginase encapsulated in red blood cells. The Orphan Europe s.a.r.l....
BioCentury | Oct 27, 2017
Clinical News

Erytech reports additional Phase IIb data for eryaspase in pancreatic cancer

...The company withdrew an MAA in November 2016 (see BioCentury, Nov. 17, 2016 ). The Orphan Europe...
BioCentury | Oct 13, 2017
Financial News

Erytech seeking NASDAQ listing

...Orphan Drug designation in the U.S. and EU for pancreatic cancer, ALL and AML. The Orphan Europe S.a.r.l....
...candidate's worldwide rights to treat pancreatic cancer. Erytech Pharma S.A. (Euronext:ERYP), Lyon, France Jennie Walters eryaspase Graspa Erytech Pharma S.A. Orphan Europe S.a.r.l. Recordati...
BioCentury | Oct 9, 2017
Financial News

Erytech seeking NASDAQ listing

...Orphan Drug designation in the U.S. and EU for pancreatic cancer, ALL and AML. The Orphan Europe S.a.r.l....
BioCentury | Apr 21, 2017
Clinical News

Graspa: Ph II start

...ALL after it withdrew the application last year (see BioCentury, Nov. 17, 2016 ). The Orphan Europe...
BioCentury | Nov 17, 2016
Clinical News

Graspa regulatory update

...new immunogenicity assay and pharmacokinetics. Graspa is L-asparaginase encapsulated inside donor-derived red blood cells. The Orphan Europe...
BioCentury | Sep 21, 2015
Clinical News

Graspa regulatory update

...to treat acute lymphoblastic leukemia (ALL). Graspa is L-asparaginase encapsulated in red blood cells. The Orphan Europe...
Items per page:
1 - 10 of 41
BioCentury | Dec 14, 2017
Clinical News

Erytech's Graspa misses in Phase IIb AML study

...company plans to start a Phase III trial of Graspa to treat pancreatic cancer. The Orphan Europe s.a.r.l....
BioCentury | Dec 8, 2017
Clinical News

Erytech sinks after Graspa miss in AML study

...company plans to start a Phase III trial of Graspa to treat pancreatic cancer. The Orphan Europe s.a.r.l....
BioCentury | Nov 17, 2017
Financial News

Erytech raises $125M, lists on NASDAQ

...for the product in November 2016. Eryaspase comprises L-asparaginase encapsulated in red blood cells. The Orphan Europe s.a.r.l....
BioCentury | Nov 15, 2017
Financial News

Erytech raises $125M, lists on NASDAQ

...for the product in November 2016. Eryaspase comprises L-asparaginase encapsulated in red blood cells. The Orphan Europe s.a.r.l....
BioCentury | Oct 27, 2017
Clinical News

Erytech reports additional Phase IIb data for eryaspase in pancreatic cancer

...The company withdrew an MAA in November 2016 (see BioCentury, Nov. 17, 2016 ). The Orphan Europe...
BioCentury | Oct 13, 2017
Financial News

Erytech seeking NASDAQ listing

...Orphan Drug designation in the U.S. and EU for pancreatic cancer, ALL and AML. The Orphan Europe S.a.r.l....
...candidate's worldwide rights to treat pancreatic cancer. Erytech Pharma S.A. (Euronext:ERYP), Lyon, France Jennie Walters eryaspase Graspa Erytech Pharma S.A. Orphan Europe S.a.r.l. Recordati...
BioCentury | Oct 9, 2017
Financial News

Erytech seeking NASDAQ listing

...Orphan Drug designation in the U.S. and EU for pancreatic cancer, ALL and AML. The Orphan Europe S.a.r.l....
BioCentury | Apr 21, 2017
Clinical News

Graspa: Ph II start

...ALL after it withdrew the application last year (see BioCentury, Nov. 17, 2016 ). The Orphan Europe...
BioCentury | Nov 17, 2016
Clinical News

Graspa regulatory update

...new immunogenicity assay and pharmacokinetics. Graspa is L-asparaginase encapsulated inside donor-derived red blood cells. The Orphan Europe...
BioCentury | Sep 21, 2015
Clinical News

Graspa regulatory update

...to treat acute lymphoblastic leukemia (ALL). Graspa is L-asparaginase encapsulated in red blood cells. The Orphan Europe...
Items per page:
1 - 10 of 41